{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T07:49:37Z","timestamp":1779176977199,"version":"3.51.4"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,11,17]],"date-time":"2010-11-17T00:00:00Z","timestamp":1289952000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"published-print":{"date-parts":[[2010,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Medium chain acyl-CoA dehydrogenase deficiency (MCADD) is a disorder of mitochondrial fatty acid oxidation and is one of the most common inborn errors of metabolism. Identification of MCADD via newborn screening permits the introduction of interventions that can significantly reduce associated morbidity and mortality. This study reports on the first three years of newborn screening for MCADD in Ontario, Canada.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Newborn Screening Ontario began screening for MCADD in April 2006, by quantification of acylcarnitines (primarily octanoylcarnitine, C8) in dried blood spots using tandem mass spectrometry. Babies with positive screening results were referred to physicians at one of five regional Newborn Screening Treatment Centres, who were responsible for diagnostic evaluation and follow-up care.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>From April 2006 through March 2009, approximately 439 000 infants were screened for MCADD in Ontario. Seventy-four infants screened positive, with a median C8 level of 0.68 uM (range 0.33-30.41 uM). Thirty-one of the screen positive infants have been confirmed to have MCADD, while 36 have been confirmed to be unaffected. Screening C8 levels were higher among infants with MCADD (median 8.93 uM) compared to those with false positive results (median 0.47 uM). Molecular testing was available for 29 confirmed cases of MCADD, 15 of whom were homozygous for the common c.985A &gt; G mutation. Infants homozygous for the common mutation tended to have higher C8 levels (median 12.13 uM) relative to compound heterozygotes for c.985A &gt; G and a second detectable mutation (median 2.01 uM). Eight confirmed mutation carriers were identified among infants in the false positive group. The positive predictive value of a screen positive for MCADD was 46%. The estimated birth prevalence of MCADD in Ontario is approximately 1 in 14 000.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The birth prevalence of MCADD and positive predictive value of the screening test were similar to those identified by other newborn screening programs internationally. We observed some evidence of correlation between genotype and biochemical phenotype (C8 levels), and between C8 screening levels and eventual diagnosis. Current research priorities include further examining the relationships among genotype, biochemical phenotype, and clinical phenotype, with the ultimate goal of improving clinical risk prediction in order to provide tailored disease management advice and genetic counselling to families.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2431-10-82","type":"journal-article","created":{"date-parts":[[2010,12,2]],"date-time":"2010-12-02T19:16:35Z","timestamp":1291317395000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["The first three years of screening for medium chain acyl-CoA dehydrogenase deficiency (MCADD) by newborn screening ontario"],"prefix":"10.1186","volume":"10","author":[{"given":"Shelley","family":"Kennedy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beth K","family":"Potter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kumanan","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Geraghty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Milburn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pranesh","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,11,17]]},"reference":[{"key":"394_CR1","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.gim.0000204472.25153.8d","volume":"8","author":"SD Grosse","year":"2006","unstructured":"Grosse SD, Khoury MJ, Greene CL, Crider KS, Pollitt RJ: The epidemiology of medium chain acyl-CoA dehydrogenase deficiency: An update. Genetics in Medicine. 2006, 8: 205-212. 10.1097\/01.gim.0000204472.25153.8d.","journal-title":"Genetics in Medicine"},{"key":"394_CR2","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0140-6736(07)60029-4","volume":"369","author":"B Wilcken","year":"2007","unstructured":"Wilcken B, Haas M, Joy P, Wiley V, Chaplin M, Black C, Fletcher J, McGill J, Boneh A: Outcome of neonatal screening for medium-chain acyl-CoA dehydrogenase deficiency in Australia: a cohort study. Lancet. 2007, 369: 37-42. 10.1016\/S0140-6736(07)60029-4.","journal-title":"Lancet"},{"key":"394_CR3","first-page":"1","volume-title":"JInherit Metab Dis","author":"B Wilcken","year":"2009","unstructured":"Wilcken B: Fatty acid oxidation disorders: outcome and long-term prognosis. JInherit Metab Dis. 2009, 1-6."},{"key":"394_CR4","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1086\/320602","volume":"68","author":"BS Andresen","year":"2001","unstructured":"Andresen BS, Dobrowolski SF, O'Reilly L, Muenzer J, McCandless SE, Frazier DM, Udvari S, Bross P, Knudsen I, Banas R, Chace DH, Engel P, Naylor EW, Gregersen N: Medium-chain acyl-CoA dehydrogenase (MCAD) mutations identified by MS\/MS-based prospective screening of newborns differ from those observed in patients with clinical symptoms: Identification and characterization of a new, prevalent mutation that results in mild MCAD deficiency. Am J Hum Genet. 2001, 68: 1408-1418. 10.1086\/320602.","journal-title":"Am J Hum Genet"},{"key":"394_CR5","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1203\/00006450-199505000-00021","volume":"37","author":"R Ziadeh","year":"1995","unstructured":"Ziadeh R, Hoffman EP, Finegold DN, Hoop RC, Brackett JC, Strauss AW, Naylor EW: Medium chain acyl-CoA dehydrogenase deficiency in Pennsylvania: Neonatal screening shows high incidence and unexpected mutation frequencies. Pediatr Res. 1995, 37: 675-678. 10.1203\/00006450-199505000-00021.","journal-title":"Pediatr Res"},{"key":"394_CR6","doi-asserted-by":"publisher","first-page":"e1108","DOI":"10.1542\/peds.2007-1993","volume":"121","author":"H Hsu","year":"2008","unstructured":"Hsu H, Zytkovicz TH, Comeau AM, Strauss AW, Marsden D, Shih VE, Grady GF, Eaton RB: Spectrum of medium-chain acyl-CoA dehydrogenase deficiency detected by newborn screening. Pediatrics. 2008, 121: e1108-e1114. 10.1542\/peds.2007-1993.","journal-title":"Pediatrics"},{"key":"394_CR7","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1007\/s10545-006-0292-1","volume":"29","author":"WJ Rhead","year":"2006","unstructured":"Rhead WJ: Newborn screening for medium-chain acyl-CoA dehydrogenase deficiency: A global perspective. J Inherit Metab Dis. 2006, 29: 370-377. 10.1007\/s10545-006-0292-1.","journal-title":"J Inherit Metab Dis"},{"key":"394_CR8","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1046\/j.1432-1033.2003.03949.x","volume":"271","author":"N Gregersen","year":"2004","unstructured":"Gregersen N, Bross P, Andresen BS: Genetic defects in fatty acid \u03b2-oxidation and acyl-CoA dehydrogenases: Molecular pathogenesis and genotype-phenotype relationships. European Journal of Biochemistry. 2004, 271: 470-482. 10.1046\/j.1432-1033.2003.03949.x.","journal-title":"European Journal of Biochemistry"},{"key":"394_CR9","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/BF03403754","volume":"99","author":"GA Horvath","year":"2008","unstructured":"Horvath GA, Davidson AGF, Stockler-Ipsiroglu SG, Lillquist YP, Waters PJ, Olpin S, Andresen BS, Palaty J, Nelson J, Vallance H: Newborn screening for MCAD deficiency: Experience of the first three years in British Columbia, Canada. Canadian Journal of Public Health. 2008, 99: 276-280.","journal-title":"Canadian Journal of Public Health"},{"key":"394_CR10","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.ymgme.2009.10.188","volume":"99","author":"GL Arnold","year":"2010","unstructured":"Arnold GL, Saavedra-Matiz CA, Galvin-Parton PA, Erbe R, DeVincentis E, Kronn D, Mofidi S, Wasserstein M, Pellegrino JE, Levy PA, Adams DJ, Nichols M, Caggana M: Lack of genotype-phenotype correlations and outcome in MCAD deficiency diagnosed by newborn screening in New York State. Mol Genet Metab. 2010, 99: 263-268. 10.1016\/j.ymgme.2009.10.188.","journal-title":"Mol Genet Metab"},{"key":"394_CR11","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.ymgme.2005.09.020","volume":"87","author":"L Waddell","year":"2006","unstructured":"Waddell L, Wiley V, Carpenter K, Bennetts B, Angel L, Andresen BS, Wilcken B: Medium-chain acyl-CoA dehydrogenase deficiency: Genotype-biochemical phenotype correlations. Mol Genet Metab. 2006, 87: 32-39. 10.1016\/j.ymgme.2005.09.020.","journal-title":"Mol Genet Metab"},{"key":"394_CR12","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1002\/humu.20163","volume":"25","author":"EM Maier","year":"2005","unstructured":"Maier EM, Liebl B, R\u00f6schinger W, Nennstiel-Ratzel U, Fingerhut R, Olgem\u00f6ller B, Busch U, Krone N, Kries RV, Roscher AA: Population spectrum of ACADM genotypes correlated to biochemical phenotypes in newborn screening for medium-chain acyl-CoA dehydrogenase deficiency. Hum Mutat. 2005, 25: 443-452. 10.1002\/humu.20163.","journal-title":"Hum Mutat"},{"key":"394_CR13","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.ymgme.2010.04.001","volume":"100","author":"EH Smith","year":"2010","unstructured":"Smith EH, Thomas C, McHugh D, Gavrilov D, Raymond K, Rinaldo P, Tortorelli S, Matern D, Highsmith WE, Oglesbee D: Allelic diversity in MCAD deficiency: the biochemical classification of 54 variants identified during five years of ACADM sequencing. Mol Genet Metab. 2010, 100: 241-250. 10.1016\/j.ymgme.2010.04.001.","journal-title":"Mol Genet Metab"},{"key":"394_CR14","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1086\/320602","volume":"68","author":"BS Andresen","year":"2001","unstructured":"Andresen BS, Dobrowolski SF, O'Reilly L, Muenzer J, McCandless SE, Frazier DM, Udvari S, Bross P, Knudsen I, Banas R, Chace DH, Engel P, Naylor EW, Gregersen N: Medium-chain acyl-CoA dehydrogenase (MCAD) mutations identified by MS\/MS-based prospective screening of newborns differ from those observed in patients with clinical symptoms: Identification and characterization of a new, prevalent mutation that results in mild MCAD deficiency. Am J Hum Genet. 2001, 68: 1408-1418. 10.1086\/320602.","journal-title":"Am J Hum Genet"},{"key":"394_CR15","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1093\/hmg\/ddp079","volume":"18","author":"EM Maier","year":"2009","unstructured":"Maier EM, Gersting SW, Kemter KF, Jank JM, Reindl M, Messing DD, Truger MS, Sommerhoff CP, Muntau AC: Protein misfolding is the molecular mechanism underlying MCADD identified in newborn screening. Hum Mol Genet. 2009, 18: 1612-1623. 10.1093\/hmg\/ddp079.","journal-title":"Hum Mol Genet"},{"key":"394_CR16","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s10545-005-0551-6","volume":"28","author":"B Blois","year":"2005","unstructured":"Blois B, Riddell C, Dooley K, Dyack S: Newborns with C8-acylcarnitine level over the 90th centile have an increased frequency of the common MCAD 985A > G mutation. J Inherit Metab Dis. 2005, 28: 551-556. 10.1007\/s10545-005-0551-6.","journal-title":"J Inherit Metab Dis"},{"key":"394_CR17","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1023\/B:BOLI.0000016636.79030.ad","volume":"27","author":"DC Lehotay","year":"2004","unstructured":"Lehotay DC, LePage J, Thompson JR, Rockman-Greenberg C: Blood acylcarnitine levels in normal newborns and heterozygotes for medium-chain acyl-CoA dehydrogenase deficiency: A relationship between genotype and biochemical phenotype?. J Inherit Metab Dis. 2004, 27: 81-88. 10.1023\/B:BOLI.0000016636.79030.ad.","journal-title":"J Inherit Metab Dis"},{"key":"394_CR18","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1056\/NEJM198811173192003","volume":"319","author":"P Rinaldo","year":"1988","unstructured":"Rinaldo P, O'Shea JJ, Coates PM, Hale DE, Stanley CA, Tanaka K: Medium-chain acyl-CoA dehydrogenase deficiency. Diagnosis by stable-isotope dilution measurement of urinary n-hexanoylglycine and 3-phenylpropionylglycine. New Engl J Med. 1988, 319: 1308-1313. 10.1056\/NEJM198811173192003.","journal-title":"New Engl J Med"},{"key":"394_CR19","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1007\/s10545-008-9976-z","volume":"31","author":"M Downing","year":"2008","unstructured":"Downing M, Manning NJ, Dalton RN, Krywawych S, Oerton J: Detection of urinary hexanoylglycine in the diagnosis of MCAD deficiency from newborn screening. J Inherit Metab Dis. 2008, 31: 550-10.1007\/s10545-008-9976-z.","journal-title":"J Inherit Metab Dis"},{"key":"394_CR20","unstructured":"Notes and queries in Metab-L: Neonatal screening for MCAD deficiency - how to deal with variant biochemical phenotypes and novel mutations?. J Inherit Metab Dis. 2008, 31: 142-145."},{"key":"394_CR21","doi-asserted-by":"publisher","first-page":"e286","DOI":"10.1542\/peds.2009-0605","volume":"125","author":"LA Prosser","year":"2010","unstructured":"Prosser LA, Kong CY, Rusinak D, Waisbren SL: Projected costs, risks, and benefits of expanded newborn screening for MCADD. Pediatrics. 2010, 125: e286-e294. 10.1542\/peds.2009-0605.","journal-title":"Pediatrics"},{"key":"394_CR22","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jpeds.2007.03.013","volume":"151","author":"CS van der Hilst","year":"2007","unstructured":"van der Hilst CS, Derks TGJ, Reijngoud D, Smit GPA, TenVergert EM: Cost-Effectiveness of Neonatal Screening for Medium Chain acyl-CoA Dehydrogenase Deficiency: The Homogeneous Population of the Netherlands. J Pediatr. 2007, 151: 115-120.e3. 10.1016\/j.jpeds.2007.03.013.","journal-title":"J Pediatr"},{"key":"394_CR23","first-page":"58","volume-title":"Ethics and newborn genetic screening. New technologies, new challenges","author":"SD Grosse","year":"2009","unstructured":"Grosse SD: Cost-effectiveness as a criterion for newborn screening policy decisions. Ethics and newborn genetic screening. New technologies, new challenges. Edited by: Baily MA, Murray TH. 2009, Baltimore: The John Hopkins University Press, 58-88."},{"key":"394_CR24","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S0140-6736(07)60005-1","volume":"369","author":"SD Grosse","year":"2007","unstructured":"Grosse SD, Dezateux C: Newborn screening for inherited metabolic disease. Lancet. 2007, 369: 5-6. 10.1016\/S0140-6736(07)60005-1.","journal-title":"Lancet"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2431-10-82.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2431-10-82\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2431-10-82","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2431-10-82.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T11:52:39Z","timestamp":1630497159000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/1471-2431-10-82"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,17]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["394"],"URL":"https:\/\/doi.org\/10.1186\/1471-2431-10-82","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,17]]},"assertion":[{"value":"20 May 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2010","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2010","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"82"}}